COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 9.845
EU - Europa 3.100
AS - Asia 630
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 4
SA - Sud America 3
OC - Oceania 2
Totale 13.604
Nazione #
US - Stati Uniti d'America 9.795
UA - Ucraina 1.111
IT - Italia 740
DE - Germania 441
CN - Cina 425
FI - Finlandia 345
IE - Irlanda 195
SE - Svezia 110
TR - Turchia 108
VN - Vietnam 48
CA - Canada 47
FR - Francia 39
GB - Regno Unito 39
BE - Belgio 21
EU - Europa 19
RU - Federazione Russa 18
IR - Iran 16
IN - India 10
KR - Corea 10
NL - Olanda 7
AT - Austria 6
JP - Giappone 5
EE - Estonia 4
CH - Svizzera 3
PL - Polonia 3
RO - Romania 3
TG - Togo 3
AU - Australia 2
BT - Bhutan 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
ME - Montenegro 2
MX - Messico 2
PT - Portogallo 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
LT - Lituania 1
PA - Panama 1
RS - Serbia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 13.604
Città #
Woodbridge 1.428
Fairfield 1.110
Ann Arbor 912
Jacksonville 795
Chandler 594
Houston 573
Ashburn 528
Dearborn 501
Wilmington 494
Seattle 450
Cambridge 370
Princeton 217
Dublin 193
Beijing 176
Udine 148
Izmir 107
San Diego 83
Boardman 55
Des Moines 48
Ogden 48
Dong Ket 47
Hefei 44
Norwalk 44
Redmond 42
Ottawa 39
Nanjing 37
Milan 35
San Mateo 32
Kunming 30
Rome 29
Brussels 21
Guangzhou 19
Helsinki 14
Mcallen 13
Trieste 13
Grafing 12
Falls Church 11
Jinan 10
Washington 10
Bologna 9
Fuzhou 9
Pignone 9
Turin 9
Vicenza 9
Indiana 8
Phoenix 8
Wuhan 8
Los Angeles 7
Hangzhou 6
Hebei 6
Leawood 6
Nanchang 6
New York 6
Tavagnacco 6
Torre Del Greco 6
Castellammare Di Stabia 5
Henderson 5
Palermo 5
Saint Petersburg 5
Simi Valley 5
Venezia 5
Vienna 5
Xian 5
Zanjan 5
Zhengzhou 5
Andover 4
Bari 4
Fontanafredda 4
Lanzhou 4
Mascali 4
Mumbai 4
Nanning 4
Paris 4
San Giuseppe Vesuviano 4
Shenyang 4
Taizhou 4
Tallinn 4
West Jordan 4
Winnipeg 4
Ardabil 3
Baotou 3
Catania 3
Changsha 3
Chengdu 3
Ferrara 3
Kashan 3
Lomé 3
Maserada Sul Piave 3
Murano 3
Nürnberg 3
Potenza 3
Pune 3
Sacramento 3
Salerno 3
Santena 3
Sirmione 3
Stezzano 3
Stra 3
Tappahannock 3
Tokyo 3
Totale 9.619
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 237
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 153
Aldosterone and the heart: from basic research to clinical evidence 142
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 141
Aldosterone and Left Ventricular Remodeling 136
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 128
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 124
Aldosterone and the heart: still an unresolved issue? 122
Aldosterone, Organ Damage, and Dietary Salt 121
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 119
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 119
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 115
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 115
The emergent cardiovascular risk factors and organ damage in arterial hypertension 114
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 114
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 114
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 114
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 113
Treatment of primary aldosteronism and organ protection 113
Benzodiazepines: an old class of new antihypertensive drugs? 112
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 111
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 111
Kidney in primary aldosteronism: a key determinant of treatment outcome 110
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 110
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 109
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 108
Salt, hypertension, and cardiovascular disease 106
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 106
Cardiovascular outcomes in patients with primary aldosteronism after treatment 106
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 106
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 104
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 104
Renal function in primary aldosteronism 101
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 101
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 101
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 100
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 99
Diabetes, diabetic complications, and blood pressure targets 99
Potassium-sparing diuretics in hypertension 98
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 98
Hypertension and type 2 diabetes: lights and shadows about causality 98
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 97
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 96
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 96
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 96
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 94
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 92
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 92
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 92
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 91
Uricaemia and left ventricular mass in hypertensive patients 91
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 91
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 88
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 88
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 88
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 88
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 88
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 87
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 87
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 86
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 86
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 86
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 85
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 85
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 84
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 83
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 83
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 82
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 81
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 77
Hyperaldosteronism and Left Ventricular Hypertrophy 77
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 76
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 76
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 75
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 75
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 75
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 74
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 74
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 73
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 73
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 72
Metabolic Dysfunction in Primary Aldosteronism 72
Effects of renal revascularization on renal and cardiac function in hypertensive patients 71
null 70
Ipertensione arteriosa e poliglobulia in paziente con stenosi multiple delle arterie renali 69
Predictive factors of left ventricular mass changes after treatment of primary aldosteronism 68
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 68
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 67
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma 66
Plasma aldosterone levels are related to urinary albumin excretion in hypertensive patients 66
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 66
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 64
Effects of omega-3 PUFA on plasma lipoprotein(a) in hypertensive patients 63
Left ventricular dysfunction and the intima-media thickness: a Tissue-Doppler study 63
Insulin resistance in the early stages of renal failure: implication for cardiovascular risk 63
Intima-media thickness and left ventricular dysfunction: a Tissue-Doppler echocardiographic study 62
Relationship between plasma aldosterone levels and albuminuria in hypertensive patients 62
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study 62
La lipoproteina(a) come fattore di rischio cardiovascolare: una revisione delle conoscenze attuali 61
Endothelial function in patients with non-alcoholic fatty liver disease 61
Totale 9.376
Categoria #
all - tutte 47.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019268 0 0 0 0 0 0 0 0 0 0 0 268
2019/20203.704 186 182 116 480 261 691 448 457 238 303 66 276
2020/20212.441 69 243 68 315 79 333 136 278 411 81 292 136
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024483 91 32 41 9 82 58 23 12 70 20 8 37
Totale 14.178